Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/612815


Republic of Korea ENT Devices Investment Opportunities, Analysis and Forecasts to 2012


Description: Republic of Korea ENT Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Republic of Korea ENT Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ENT Devices in Republic of Korea

Scope

- The report provides ENT devices information broken down into detailed categories and segments in Republic of Korea.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the ENT devices market in Republic of Korea.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 2
1.1 List of Tables 10
1.2 List of Figures 12
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered 14
3.1 ENT Devices 14
3.2 Hearing Aid Devices 14
3.2.1 Analog Hearing Devices 14
3.2.2 Digital Signal Processing Hearing Aid (DSP) 14
3.3 Hearing Implants 14
3.3.1 Cochlear Implant 14
3.3.2 Bone Anchored Hearing Implant 14
3.4 Diagnostic Devices 14
3.4.1 Audiometer 15
3.4.2 Otoscope 15
4 Healthcare Sector Review 16
4.1 Healthcare Expenditure 16
4.2 Healthcare Infrastructure 18
4.3 Healthcare Policy 23
5 Regulation System 24
5.1 Medical Equipment Approval Process 24
5.1.1 Classification 24
5.1.2 Premarket Notification for Class I Devices 25
5.1.3 Pre-market Approval for Class II, III and IV Devices 25
5.1.3.1 Technical Review: 25
5.1.3.2 Type Testing: 26
5.1.3.3 Applying for Product License: 26
5.1.3.4 KGMP Certification 26
5.1.4 License Fee 26
5.1.5 License Application Processing Duration 26
5.2 Post-market Surveillance 27
6 Pricing and Reimbursement 28
7 Distribution Structure 31
7.1 Distribution Structure 31
8 ENT Devices in Republic of Korea 32
8.1 ENT Devices Overall Revenues (2000-2012) 32
8.2 ENT Devices Overall Volume (2000-2012) 36
8.3 ENT Devices Overall Company Shares (2006-2007) 38
9 Hearing Aid Devices in Republic of Korea 39
9.1 Hearing Aid Devices Overall Revenues (2000-2012) 39
9.2 Hearing Aid Devices Overall Volume (2000-2012) 41
9.3 Hearing Aid Devices Average Price 43
9.4 Hearing Aid Devices Distribution Share (2006-2007) 43
9.5 Hearing Aid Devices Company Share (2006-2007) 44
10 Hearing Implants in Republic of korea 45
10.1 Hearing Implants Overall Revenues (2000-2012) 45
10.2 Hearing Implants Overall Volume (2000-2012) 47
10.3 Hearing Implants Average Price 49
10.4 Hearing Implants Distribution Share (2006-2007) 49
10.5 Hearing Implants Company Share (2006-2007) 50
11 Diagnostic Devices in Republic of Korea 51
11.1 Diagnostic Devices Overall Revenues (2000-2012) 51
11.2 Diagnostic Devices Overall Volume (2000-2012) 53
11.3 Diagnostic Devices Average Price 55
11.4 Diagnostic Devices Distribution Share (2006-2007) 55
11.5 Diagnostic Devices Company Share (2006-2007) 56
12 William Demant Holding A/S Company Profile 57
12.1 Company Overview 57
12.2 Business Overview 57
12.2.1 Hearing and Communication Devices and Equipment 57
12.2.1.1 Overview 57
12.2.1.2 Financials 57
12.2.1.3 Market View 57
12.2.1.4 Key Strategies 58
12.2.2 Products 58
12.2.3 History 59
12.3 Value Chain Analysis 61
12.3.1 Manufacturing 61
12.3.1.1 In House Manufacturing 61
12.3.2 Product Development 61
12.3.2.1 Regulatory Approvals 61
12.3.2.2 Clinical Trials 62
12.3.2.3 Research and Development 62
12.3.3 Sales and Marketing 62
12.3.3.1 Partnerships and Alliances 62
12.4 SWOT Analysis 63
12.4.1 William Demant Holding A/S Strengths 63
12.4.1.1 High revenues and gross margin 63
12.4.1.2 High returns 63
12.4.1.3 Strong R&D activities 64
12.4.2 William Demant Holding A/S Weaknesses 64
12.4.2.1 Lack of geographic diversity 64
12.4.2.2 Weak performance of Asian operations 64
12.4.3 William Demant Holding A/S Opportunities 64
12.4.3.1 New product launches 64
12.4.3.2 Awards 65
12.4.3.3 RISE technology 65
12.4.4 William Demant Holding A/S Threats 65
12.4.4.1 Entry of new technologies 65
12.4.4.2 Strong competition 65
12.5 Financial and Operational Review 66
12.5.1 Financial Statements 66
12.5.2 Financial Ratios 67
12.6 Locations and Subsidiaries 68
12.7 Other Locations & Subsidiaries 68
12.8 Recent Developments 70
12.8.1 Mar 06, 2008: William Demant Reports 2007 Results 70
12.8.2 Aug 16, 2007: William Demant Reports H1 2007 Results 71
13 Cochlear Ltd. Company Profile 73
13.1 Company Overview 73
13.2 Business Overview 73
13.2.1 Implantable hearing devices 73
13.2.1.1 Overview 73
13.2.1.2 Financials 73
13.2.1.3 Market View 73
13.2.1.4 Key Strategies 73
13.2.2 Products 73
13.2.3 History 74
13.3 Value Chain Analysis 77
13.3.1 Manufacturing 77
13.3.1.1 In House Manufacturing 77
13.3.2 Product Development 77
13.3.2.1 Regulatory Approvals 77
13.3.2.2 Clinical Trials 78
13.3.2.3 Research and Development 78
13.3.3 Sales and Marketing 78
13.3.3.1 Partnerships and Alliances 78
13.3.3.2 Licensing Agreements 79
13.3.3.3 E-distribution 79
13.4 SWOT Analysis 79
13.4.1 Cochlear Limited Strengths 80
13.4.1.1 Consistent revenue growth 80
13.4.1.2 High returns 80
13.4.1.3 Worldwide existence 80
13.4.2 Cochlear Limited Weaknesses 80
13.4.2.1 Lower turnover ratios 80
13.4.3 Cochlear Limited Opportunities 80
13.4.3.1 Acquisitions 80
13.4.3.2 High profile industry meetings 81
13.4.3.3 2007 DHL Australian Exporter of the Year 81
13.4.4 Cochlear Limited Threats 81
13.4.4.1 Technological developments 81
13.4.4.2 Changes in reimbursement policies 81
13.5 Financial and Operational Review 82
13.5.1 Financial Statements 82
13.5.2 Financial Ratios 83
13.6 Locations and Subsidiaries 84
13.7 Other Locations & Subsidiaries 84
13.8 Recent Developments 86
13.8.1 Aug 14, 2007: Cochlear Declares Final Dividend 86
13.8.2 Aug 14, 2007: Cochlear Reports Fiscal 2007 Results 86
13.8.3 Feb 13, 2007: Cochlear Reports H1 Fiscal 2007 Results 87
13.8.4 Aug 15, 2006: Cochlear Reports Fiscal 2006 Results 87
13.8.5 Dec 15, 2006: Cochlear Appoints New Board Member 87
13.8.6 Jul 18, 2006: Cochlear Board Members to Retire 88
14 GN ReSound A/S Company Profile 89
14.1 Company Overview 89
14.2 Business Overview 89
14.2.1 Products 90
14.2.2 History 90
14.3 Locations and Subsidiaries 91
14.4 Other Locations & Subsidiaries 91
14.5 Recent Developments 93
14.5.1 Feb 22, 2007: GN Repots Year-End 2006 Results 93
15 Phonak Holding AG Company Profile 94
15.1 Company Overview 94
15.2 Business Overview 94
15.2.1 Hearing systems and related products 94
15.2.1.1 Overview 94
15.2.1.2 Financials 94
15.2.1.3 Market View 94
15.2.1.4 Key Strategies 94
15.2.2 Products 95
15.2.3 History 95
15.3 Value Chain Analysis 97
15.3.1 Manufacturing 97
15.3.1.1 In House Manufacturing 97
15.3.2 Product Development 98
15.3.2.1 Regulatory Approvals 98
15.3.2.2 Clinical Trials 98
15.3.2.3 Research and Development 98
15.3.3 Sales and Marketing 98
15.3.3.1 Partnerships and Alliances 98
15.3.3.2 E-distribution 98
15.4 SWOT Analysis 99
15.4.1 Phonak Holding AG Strengths 99
15.4.1.1 Stable revenue growth 99
15.4.1.2 High returns 99
15.4.2 Phonak Holding AG Weaknesses 100
15.4.2.1 High selling, marketing, general and administrative expenses 100
15.4.2.2 Lack of geographic diversification 100
15.4.3 Phonak Holding AG Opportunities 100
15.4.3.1 New products 100
15.4.3.2 Hear the World initiative 100
15.4.4 Phonak Holding AG Threats 100
15.4.4.1 Innovative technologies 100
15.4.4.2 Change in market conditions 101
15.5 Financial and Operational Review 101
15.5.1 Financial Statements 101
15.5.2 Financial Ratios 102
15.6 Locations and Subsidiaries 103
15.7 Other Locations & Subsidiaries 103
15.8 Recent Developments 105
15.8.1 Nov 13, 2007: Sonova Declares H1 Fiscal 2008 Results 105
15.8.2 May 15, 2007: Phonak Reports 2006/2007 Results 106
15.8.3 Nov 15, 2006: Phonak Declares 2007 Interim Results 106
15.8.4 Jun 01, 2006: Phonak Reports 2005/2006 Results 108
15.8.5 Aug 01, 2007: Phonak Changes Its Name To Sonova Holding AG 108
16 Sonic Innovations, Inc. Company Profile 109
16.1 Company Overview 109
16.2 Business Overview 109
16.2.1 Products 110
16.3 Locations and Subsidiaries 110
16.4 Other Locations & Subsidiaries 111
16.5 Recent Developments 112
16.5.1 Apr 03, 2008 Sonic Innovations Launches Its Novel ion 400 112
16.5.2 Apr 03, 2008 Sonic Innovations Launches Velocity miniBTE 112
16.5.3 Mar 05, 2008 Sonic Innovations, Inc. Adds Automatic Features To Its Smallest Hearing Aid ion 400 113
16.5.4 Jan 29, 2007: Sonic and Amplifon Sign Agreement 113
16.5.5 Jan 29, 2007: Sonic and Amplifon Sign Agreement 113
16.5.6 May 13, 2008: Sonic Announces Board Changes 113
16.5.7 Dec 19, 2006: Sonic Elects New Board Members 114
17 Appendix 115
17.1 Global Markets Direct Research Methodology 115
17.2 Coverage 116
17.3 Secondary Research 116
17.4 Primary Research 117
17.5 Models 117
17.6 Forecasts 118
17.7 Expert Panels 118
17.8 Currency Conversion 119
17.9 Contact Us 120
17.10 Disclaimer 120

1.1 List of Tables
Table 1: Hospital Wards by Specialty in Republic of Korea, 2003-2007 20
Table 2: Doctors by Specialty in Republic of Korea, 2003-2007 21
Table 3: Healthcare Institutions in Republic of Korea, 2001-2005 22
Table 4: Healthcare Personnel in Republic of Korea, 1975-2002 22
Table 5: Classification of Medical Equipment in Republic of Korea 24
Table 6: ENT Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 32
Table 7: ENT Devices Market, Republic of Korea, Portfolio Analysis 33
Table 8: ENT Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 34
Table 9: ENT Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 35
Table 10: ENT Devices, Republic of Korea, Overall Volume (Units), 2000-2012 36
Table 11: ENT Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 36
Table 12: ENT Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 37
Table 13: Hearing Implants, Republic of Korea, Overall Company Share by Revenue ($ mn), 2006-2007 38
Table 14: Hearing Aid Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 39
Table 15: Hearing Aid Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 40
Table 16: Hearing Aid Devices, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 41
Table 17: Hearing Aid Devices, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 42
Table 18: Hearing Aid Devices, Republic of Korea, Average Price ($), Historic, 2000-2007 43
Table 19: Hearing Aid Devices, Republic of Korea, Average Price ($), Forecast, 2007-20012 43
Table 20: Hearing Aid Devices, Republic of Korea, Distribution Share by Revenue ($ mn), 2006-2007 43
Table 21: Hearing Aid Devices, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007 44
Table 22: Hearing Implants, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 45
Table 23: Hearing Implants, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Table 24: Hearing Implants, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 47
Table 25: Hearing Implants, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 48
Table 26: Hearing Implants, Republic of Korea, Average Price ($), Historic, 2000-2007 49
Table 27: Hearing Implants, Republic of Korea, Average Price ($), Forecast, 2007-2012 49
Table 28: Hearing Implants, Republic of Korea, Distribution Share by Revenue ($ mn), 2006-2007 49
Table 29: Hearing Implants, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007 50
Table 30: Diagnostic Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 51
Table 31: Diagnostic Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 52
Table 32: Diagnostic Devices, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 53
Table 33: Diagnostic Devices, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 54
Table 34: Diagnostic Devices, Republic of Korea, Average Price ($), Historic, 2000-2007 55
Table 35: Diagnostic Devices, Republic of Korea, Average Price ($), Forecast, 2007-2012 55
Table 36: Diagnostic Devices, Republic of Korea, Distribution Share by Revenue ($ mn), 2006-2007 55
Table 37: Diagnostic Devices, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007 56
Table 38: William Demant Holding A/S, SWOT Analysis, 2007 63
Table 39: William Demant Holding A/S, Financial Statements, Danish Krone Thousand, 2003-2007 66
Table 40: William Demant Holding A/S, Financial Ratios, Danish Krone Thousand, 2003-2007 67
Table 41: William Demant Holding A/S, Subsidiaries 68
Table 42: Cochlear Limited, SWOT Analysis, 2007 79
Table 43: Cochlear Limited, Financial Statements, A$ Thousand, 2003-2007 82
Table 44: Cochlear Limited, Financial Ratios, A$ Thousand, 2003-2007 83
Table 45: Cochlear Limited, Subsidiaries 84
Table 46: GN ReSound A/S, Other Locations 91
Table 47: GN ReSound A/S, Subsidiaries 92
Table 48: Phonak Holding AG, SWOT Analysis, 2007 99
Table 49: Phonak Holding AG, Financial Statements, Swiss Franc Thousand, 2003-2007 101
Table 50: Phonak Holding AG, Financial Ratios, Swiss Franc Thousand, 2003-2007 102
Table 51: Phonak Holding AG, Other Locations 103
Table 52: Phonak Holding AG, Subsidiaries 105
Table 53: Sonic Innovations, Inc., Subsidiaries 111
Table 54: Currency Conversion from USD to Local Currency at 2007 Constant Rate 119

1.2 List of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007 17
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006 18
Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007 29
Figure 4: Medical Device Pricing System in Republic of Korea, 2007 30
Figure 5: ENT Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 32
Figure 6: ENT Devices Market, Republic of Korea, Portfolio Analysis 33
Figure 7: ENT Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 34
Figure 8: ENT Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure 9: Hearing Implants, Republic of Korea, Overall Company Share (%), 2007 38
Figure 10: Hearing Aid Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 39
Figure 11: Hearing Aid Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 40
Figure 12: Hearing Aid Devices, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 41
Figure 13: Hearing Aid Devices, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 42
Figure 14: Hearing Aid Devices, Republic of Korea, Company Share (%), 2007 44
Figure 15: Hearing Implants, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 16: Hearing Implants, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 17: Hearing Implants, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 47
Figure 18: Hearing Implants, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 48
Figure 19: Hearing Implants, Republic of Korea, Company Share (%), 2007 50
Figure 20: Diagnostic Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Historic, 2000-2007 51
Figure 21: Diagnostic Devices, Republic of Korea, Overall Revenue ($ mn) by Segment, Forecast, 2007-2012 52
Figure 22: Diagnostic Devices, Republic of Korea, Overall Volume (Units) by Segment, Historic, 2000-2007 53
Figure 23: Diagnostic Devices, Republic of Korea, Overall Volume (Units) by Segment, Forecast, 2007-2012 54
Figure 24: Diagnostic Devices, Republic of Korea, Company Share (%), 2007 56
Figure 25: William Demant Holding A/S, Value Chain Analysis 61
Figure 26: Cochlear Limited, Value Chain Analysis 77
Figure 27: Phonak Holding AG, Value Chain Analysis 97
Figure 28: Our Methodology115


Companies Mentioned William Demant Holding A/S Cochlear Ltd. GN ReSound A/S Phonak Holding AG Sonic Innovations, Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/612815

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 08:50:09
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Republic of Korea ENT Devices Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/612815
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 08:50:09

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)